AARP Report: Most-Favored-Nation Pricing for Top Drugs Could Reduce Medicare Spending by Nearly $200 Billion, Lower Drug Costs Further for Older Adults
August 07, 2026
August 07, 2026
WASHINGTON, Aug. 7 (TNSrpt) -- AARP issued the following news release on Aug. 6, 2026:
* * *
AARP Report: Most-Favored-Nation Pricing for Top Drugs Could Reduce Medicare Spending by Nearly $200 Billion, Lower Drug Costs Further for Older Adults
AARP today called for strengthening Medicare's prescription drug price negotiation program after new analysis found doing so could reduce Medicare spending nearly $200 billion over five years while making lifesa . . .
* * *
AARP Report: Most-Favored-Nation Pricing for Top Drugs Could Reduce Medicare Spending by Nearly $200 Billion, Lower Drug Costs Further for Older Adults
AARP today called for strengthening Medicare's prescription drug price negotiation program after new analysis found doing so could reduce Medicare spending nearly $200 billion over five years while making lifesa . . .